Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2021

View Archived Issues

Albireo Pharma presents preclinical data on HBV entry inhibitor A-2342

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

B-cell GABA release blunts tumor immune response

New antibacterials identified at Roche

Iomx Therapeutics divulges new SIK2/SIK3 inhibitors

BeiGene describes BTK-targeting PROTACs

Jiangsu Hengrui Medicine and collaborators patent inositol derivatives

New kappa-opioid receptor agonists discovered at Medshine Discovery

Novel mouse model of focal limbic seizures with impaired behavior

PTSD model developed in Jeju minipig

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Guard reports preclinical data on ROSgard in animal models of sepsis

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...